Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma.
Sequana Therapeutics Inc., La Jolla, California 92037, USA.
L
L
Zuo
J
J
Weger
Q
Q
Yang
A M
AM
Goldstein
M A
MA
Tucker
G J
GJ
Walker
N
N
Hayward
N C
NC
Dracopoli
D001483:Base Sequence; D002352:Carrier Proteins / Q000378:metabolism; D051358:Cyclin-Dependent Kinase 4; D019941:Cyclin-Dependent Kinase Inhibitor p16; D018844:Cyclin-Dependent Kinases / Q000235:genetics* / Q000378:metabolism; D017931:DNA Primers / Q000737:chemistry; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000235:genetics*; D008969:Molecular Sequence Data; D010375:Pedigree; D018807:Polymorphism, Single-Stranded Conformational; D011518:Proto-Oncogene Proteins
D002352:Carrier Proteins; D019941:Cyclin-Dependent Kinase Inhibitor p16; D017931:DNA Primers; D011518:Proto-Oncogene Proteins; C495900:CDK4 protein, human; D051358:Cyclin-Dependent Kinase 4; D018844:Cyclin-Dependent Kinases